Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deep LS
Darmstadt, Hesse, Germanydeep-ls.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Deep LS provides an AI-driven software platform that accelerates the design and optimization of new small molecule drug candidates. The platform enables pharmaceutical and biotech companies to generate novel active ingredients with desired biological properties, streamlining multiple sub-processes in early-stage drug development. The company operates primarily on a project or license basis with pharma/biotech partners in EMEA, aiming to expand into the US market
- Therapeutic areas
- Other
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
02
Partnerships
Pharmaceutical and biotech companies in EMEA region; specific names not disclosed
Beyond the preview
Go deeper on Deep LS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Deep LS.